Hodgkin’s Lymphoma vs Non-Hodgkin’s Lymphoma: Types you need to know

Lymphoma is a common type of blood cancer that affects the lymphatic system, an essential part of the body’s immune defense. It develops when certain white blood cells, including B cells or T cells, grow uncontrollably, leading to tumors or enlarged lymph nodes.
Thanks to advances in oncology and targeted therapies, outcomes for people with lymphoma have improved significantly. Treatments such as chemotherapy regimens, personalized cancer therapies, and monoclonal antibodies like rituximab help control the disease while maintaining patients’ quality of life.
Modern lymphoma care combines scientific expertise with comprehensive patient support. This ensures individuals diagnosed with Hodgkin’s lymphoma or non-Hodgkin’s lymphoma can face their condition with confidence and access to specialized medical care.
What is Lymphoma?
Lymphoma begins in lymphocytes, the white blood cells that protect the body from infections. These cells can grow uncontrollably, forming tumors in the lymphatic system, which includes the lymph nodes, spleen, bone marrow, and other immune organs.
Accurate and early diagnosis is essential for determining the appropriate treatment. Depending on the type and stage, management may range from monitoring slow-growing cases to aggressive therapies, including chemotherapy or stem cell transplants.
Symptoms of Lymphoma
Symptoms of lymphoma often develop gradually and may appear mild at first, which can delay medical attention. Recognizing early warning signs is important, especially because lymphoma can affect the lymph nodes and other parts of the immune system.
Common symptoms include:
Swollen lymph nodes (lymphadenopathy): Painless lumps in the neck, armpits, or groin that do not disappear
Unexplained fever: Persistent fever without a clear infection
Night sweats: Heavy sweating during sleep that may require changing clothes or bedding
Fatigue: Ongoing tiredness that does not improve with rest
Unintentional weight loss: Losing weight without changes in diet or activity
Itchy skin: Generalized or patchy itching without an obvious cause
Persistent cough or chest discomfort: When enlarged lymph nodes are located in the chest area
Abdominal swelling or pain: Sometimes linked to an enlarged spleen or lymph nodes in the abdomen
It is important to note that these symptoms can also be caused by other, non-cancerous conditions. Only a medical evaluation, including appropriate tests such as a biopsy or imaging, can confirm whether lymphoma is present.
Hodgkin’s Lymphoma vs Non-Hodgkin’s Lymphoma
Lymphoma is generally classified into two main categories: Hodgkin’s lymphoma and Non-Hodgkin’s lymphoma. Understanding the differences between these two types is essential because they vary in how they develop, spread through the body, and respond to treatment.
In many cases:
Hodgkin’s lymphoma tends to spread in a more predictable, nodal pattern, moving step by step from one lymph node group to another.
Non-Hodgkin’s lymphoma (NHL) may spread in a more variable way, sometimes involving organs outside the lymph nodes, such as the bone marrow or digestive tract.
Although these patterns help guide staging and prognosis, the exact behavior depends on the lymphoma subtype and the individual patient.
Hodgkin’s Lymphoma
Hodgkin’s lymphoma is a distinct type of lymphoma identified by the presence of abnormal cells called Reed-Sternberg cells. These cells are detected through a biopsy, which is a key step in confirming the diagnosis.
Hodgkin’s lymphoma often begins in the lymph nodes and is considered one of the most treatable lymphoid malignancies, especially when diagnosed early.
Key Facts
Most commonly affects adolescents and young adults, but it can occur at any age
Typical symptoms include painless enlarged lymph nodes, fever, night sweats, and unexplained weight loss
Usually progresses in an orderly, predictable way from one nodal region to another
Hodgkin’s Lymphoma Subtypes
Hodgkin’s lymphoma includes several subtypes, each with different clinical behavior and treatment considerations. The two major forms are
Classical Hodgkin Lymphoma (cHL)
Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Classical Hodgkin lymphoma can be further divided into subtypes such as
Nodular sclerosis
Mixed cellularity
Lymphocyte-rich
Lymphocyte-depleted
These subtypes may differ in aggressiveness, response to therapy, and overall prognostic outlook.
Treatment options for Hodgkin’s Lymphoma
Treatment depends on the stage and subtype, but common approaches include:
Chemotherapy regimens, such as the well-established ABVD protocol
Radiation therapy, particularly in early or localized disease
Supportive care to manage side effects like fatigue, nausea, or infection risk
Long-term follow-up to monitor for relapse or late treatment effects
Overall, Hodgkin’s lymphoma has a high treatment success rate, and many patients achieve long-term remission and recovery.
Non-Hodgkin Lymphoma
Non-Hodgkin lymphoma (NHL) refers to a large group of lymphomas that do not involve Reed-Sternberg cells, which distinguishes it from Hodgkin’s lymphoma. NHL includes more than 60 different subtypes, making it a highly diverse category of lymphoid malignancies.
Some of the most common subtypes include:
Diffuse Large B-Cell Lymphoma (DLBCL),a fast-growing large cell lymphoma
Follicular lymphoma, often slow-growing
Mantle cell lymphoma
Burkitt lymphoma, an aggressive form
Peripheral T-cell lymphoma, which develops from T lymphocytes
Non-Hodgkin lymphoma can start in the lymph nodes, but it may also appear in other organs such as the skin, stomach, or bone marrow. Depending on the subtype, NHL may be indolent (slow-growing) or high-grade (aggressive).
Key facts
More common in older adults, although it can occur at any age
Symptoms often include enlarged lymph nodes, fatigue, fever, and unexplained weight loss
May involve multiple sites in the body and spread in an unpredictable way
Treatment options for Non-Hodgkin Lymphoma
Treatment depends on the subtype, stage, and whether the disease is aggressive or slow-growing. Common approaches include:
Chemotherapy regimens, such as CHOP, often used for aggressive lymphomas
Immunotherapy, including monoclonal antibodies like Rituximab, especially in B-cell lymphomas
Targeted therapies, which block specific pathways that support cancer cell growth
Stem cell transplant (autologous or allogeneic) in cases of relapsed or refractory lymphoma
Radiation therapy, mainly for localized tumors or symptom relief
Long-term follow-up and supportive care to monitor remission and quality of life
The outlook for Non-Hodgkin lymphoma varies widely depending on the subtype and how early it is diagnosed. However, ongoing advances in treatment have significantly improved survival outcomes for many patients.
Key differences between Hodgkin’s Lymphoma and Non-Hodgkin’s Lymphoma
Although both diseases affect the lymphatic system and are classified as lymphoid malignancies, Hodgkin’s lymphoma and non-Hodgkin’s lymphoma (NHL) differ in their cellular features, progression patterns, subtype diversity, and treatment strategies.
The table below summarizes the main distinctions between the two:
| Feature | Hodgkin’s Lymphoma | Non-Hodgkin’s Lymphoma (NHL) |
|---|---|---|
| Characteristic cell | Presence of Reed-Sternberg cells | Absence of Reed-Sternberg cells |
| Typical age group | More common in young adults (20 to 35 years),but can occur at any age | More common in older adults, though it can affect all age groups |
| Pattern of progression | Usually spreads in an orderly, nodal pattern from one lymph node group to another | Often spreads unpredictably and may involve multiple organs such as bone marrow or skin |
| Subtype variability | Fewer, more clearly defined subtypes | Over 60 subtypes, including slow-growing and aggressive forms (e.g., large cell lymphoma, T-cell lymphoma) |
| Treatment approach | Often responds well to chemotherapy regimens such as ABVD and radiotherapy | Treatment is more individualized and may include chemotherapy, monoclonal antibodies (e.g., Rituximab),targeted therapy, or stem cell transplant |
| Prognosis | Generally high cure and long-term remission rates | Prognosis varies widely depending on subtype, stage, and response to treatment |
This comparison helps clarify why distinguishing between Hodgkin’s lymphoma and non-Hodgkin’s lymphoma is essential for accurate diagnosis, staging, and choosing the most appropriate therapy.
Living with Lymphoma: Support and care
A lymphoma diagnosis affects more than physical health. Emotional well-being, social support, and long-term follow-up are all important parts of living with Hodgkin’s lymphoma or non-Hodgkin’s lymphoma, both during and after treatment.
Supportive care may include:
Counseling and support groups: Helping patients and families share experiences, reduce isolation, and build coping strategies
Nutritional guidance: Supporting strength and recovery, especially during chemotherapy regimens or immunotherapy
Physical rehabilitation: Exercises and therapies that reduce fatigue and improve daily functioning
Patient education: Understanding the disease, treatment options, and remission monitoring empowers individuals to take an active role in their care
Because lymphoma can sometimes relapse or require long-term management, ongoing medical follow-up is essential to track recovery and overall quality of life.
When to seek medical advice
If you or a loved one has been diagnosed with lymphoma or is experiencing persistent symptoms such as enlarged lymph nodes, fever, or unexplained weight loss, it is important to consult a qualified healthcare professional or an experienced oncologist.
Hospitals with specialized hematology and oncology teams, such as Biruni Hospital, provide diagnostic services and comprehensive care